Lineage Cell Therapeutics, Inc. Grants Receivable, Current
Lineage Cell Therapeutics, Inc. (LCTX) had Grants Receivable, Current of $200.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-11.
Discontinued › Notes › Nontrade Receivables
us-gaap:GrantsReceivableCurrent · last filed 2022-08-11
- 2022-06-30: Grants Receivable, Current $200.00K.
- 2021-12-31: Grants Receivable, Current $200.00K.
- 2019-12-31: Grants Receivable, Current $273.00K.
- 2018-12-31: Grants Receivable, Current $716.00K.
| Period end | Grants Receivable, Current | Grants Receivable, Current as first filed |
|---|---|---|
| 2022-06-30 | $200.00K 10-Q · filed 2022-08-11 | |
| 2021-12-31 | $200.00K 10-Q · filed 2022-08-11 | |
| 2019-12-31 | $273.00K 10-K · filed 2020-03-12 | |
| 2018-12-31 | $716.00K 10-K · filed 2020-03-12 | |
| 2017-12-31 | $641.00K 10-K · filed 2019-03-14 | |
| 2016-12-31 | $102.00K 10-K · filed 2018-03-15 | |
| 2015-12-31 | $324.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $280.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $434.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $260.30K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $493.00K 10-K · filed 2016-03-15 | $492.60K 10-K · filed 2015-03-11 |
| 2014-09-30 | $452.60K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $678.30K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $334.70K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $539.30K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $143.00K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $1.34M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $699.00K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $1.06M 10-K · filed 2014-03-17 | $353.00K 10-K · filed 2013-03-18 |
| 2012-09-30 | $38.00K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $120.00K 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $630.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |